Whether electroCore (ECOR) represents a sound investment depends on your appetite for small-cap medical device volatility. While analysts point to expanding revenue growth and rising adoption of its non-invasive nerve stimulation therapies, the company continues to work toward sustained GAAP profitability. What is your specific risk profile and portfolio strategy?